Cargando…

Characterization of the blood brain barrier in pediatric central nervous system neoplasms

OBJECTIVE: The normal blood–brain barrier (BBB) is composed of tight junctions between endothelial cells and surrounding astrocyte foot processes. Breakdown of the physiological astrocyte-endothelial cell relationship occurs in adult metastatic and primary brain tumors. However, the astrocyte-endoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Christopher S., Ho, Winson, Piazza, Martin G., Ray-Chaudhury, Abhik, Zhuang, Zhengping, Heiss, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132180/ https://www.ncbi.nlm.nih.gov/pubmed/27917302 http://dx.doi.org/10.5455/jihp.20160623053540

Ejemplares similares

PP2A inhibition with LB100 enhances cisplatin cytotoxicity and overcomes cisplatin resistance in medulloblastoma cells
por: Ho, Winson S., et al.
Publicado: (2016)

A dynamic in vivo-like organotypic blood-brain barrier model to probe metastatic brain tumors
por: Xu, Hui, et al.
Publicado: (2016)

Role of the Blood-Brain Barrier in Central Nervous System Insulin Resistance
por: Rhea, Elizabeth M., et al.
Publicado: (2019)

Modeling the blood-brain barrier for treatment of central nervous system (CNS) diseases
por: Rice, Olivia, et al.
Publicado: (2022)

MicroRNAs in pediatric central nervous system embryonal neoplasms: the known unknown
por: Braoudaki, Maria, et al.
Publicado: (2015)

Multiple Sclerosis and the Blood-Central Nervous System Barrier
por: Palmer, Alan M.
Publicado: (2013)

Pathways for Small Molecule Delivery to the Central Nervous System Across the Blood-Brain Barrier
por: Mikitsh, John L, et al.
Publicado: (2014)

Pathways Exploited by Flaviviruses to Counteract the Blood-Brain Barrier and Invade the Central Nervous System
por: Mustafá, Yasmin Mucunã, et al.
Publicado: (2019)

Involvement of noncoding RNA in blood-brain barrier integrity in central nervous system disease
por: Liu, Xi, et al.
Publicado: (2021)

Secondary Neoplasms of the Central Nervous System and Meninges
por: Meyer, P. C., et al.
Publicado: (1953)

The role of cytokines and chemokines in the microenvironment of the blood–brain barrier in leukemia central nervous system metastasis
por: Si, Mengya, et al.
Publicado: (2018)

Structure, Function, and Regulation of the Blood-Brain Barrier Tight Junction in Central Nervous System Disorders
por: Lochhead, Jeffrey J., et al.
Publicado: (2020)

Non-coding RNAs in the regulation of blood–brain barrier functions in central nervous system disorders
por: Sun, Ping, et al.
Publicado: (2022)

Risk of Second Primary Neoplasms of the Central Nervous System
por: Liu, Elisa K., et al.
Publicado: (2022)

The Role of VE-cadherin in Blood-brain Barrier Integrity under Central Nervous System Pathological Conditions
por: Li, Wenlu, et al.
Publicado: (2018)

Encephalitic Alphaviruses Exploit Caveola-Mediated Transcytosis at the Blood-Brain Barrier for Central Nervous System Entry
por: Salimi, Hamid, et al.
Publicado: (2020)

Blood-brain Barrier Damage is Pivotal for SARS-CoV-2 Infection to the Central Nervous System
por: Rodríguez-Morales, Jahir, et al.
Publicado: (2022)

The Blood–Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults
por: Haddad, Nicholas, et al.
Publicado: (2022)

Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target
por: Sizdahkhani, Saman, et al.
Publicado: (2017)

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma
por: Fang, Francia Y., et al.
Publicado: (2022)

Next generation of non-mammalian blood-brain barrier models to study parasitic infections of the central nervous system
por: Siddiqui, Ruqaiyyah, et al.
Publicado: (2012)

Acanthamoeba produces disseminated infection in locusts and traverses the locust blood-brain barrier to invade the central nervous system
por: Mortazavi, Parisa N, et al.
Publicado: (2010)

DARC shuttles inflammatory chemokines across the blood–brain barrier during autoimmune central nervous system inflammation
por: Minten, Carsten, et al.
Publicado: (2014)

Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of Stroke
por: Brzica, Hrvoje, et al.
Publicado: (2017)

Blood-Brain Barrier: More Contributor to Disruption of Central Nervous System Homeostasis Than Victim in Neurological Disorders
por: Xiao, Minjia, et al.
Publicado: (2020)

Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning
por: Morofuji, Yoichi, et al.
Publicado: (2020)

Biomarkers Reflecting The Destruction Of The Blood-Brain Barrier Are Valuable In Predicting The Risk Of Lymphomas With Central Nervous System Involvement
por: Yu, Wenjun, et al.
Publicado: (2019)

Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms
por: Braoudaki, Maria, et al.
Publicado: (2014)

Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood–brain barrier, and invades the central nervous system
por: Tian, Debin, et al.
Publicado: (2022)

Endogenous Retroviral Elements in Human Development and Central Nervous System Embryonal Tumors
por: Doucet-O’Hare, Tara T., et al.
Publicado: (2021)

The Continuing Value of Ultrastructural Observation in Central Nervous System Neoplasms in Children
por: Kim, Na Rae, et al.
Publicado: (2015)

Tumour necrosis factor-α mediates blood—brain barrier damage in HIV-1 infection of the central nervous system
por: Sharief, M. K., et al.
Publicado: (1992)

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease
por: Hanson, Leah R, et al.
Publicado: (2008)

Blood–Brain Barrier Function and Biomarkers of Central Nervous System Injury in Rickettsial versus Other Neurological Infections in Laos
por: Dittrich, Sabine, et al.
Publicado: (2015)

Imaging P‐Glycoprotein Function at the Blood–Brain Barrier as a Determinant of the Variability in Response to Central Nervous System Drugs
por: Bauer, Martin, et al.
Publicado: (2019)

Borneol, a novel agent that improves central nervous system drug delivery by enhancing blood–brain barrier permeability
por: Zhang, Qun-Lin, et al.
Publicado: (2017)

Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
por: Burks, Susan M., et al.
Publicado: (2021)

Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions
por: Proust, Alizé, et al.
Publicado: (2023)

Targeting AAV vectors to the central nervous system by engineering capsid–receptor interactions that enable crossing of the blood–brain barrier
por: Huang, Qin, et al.
Publicado: (2023)

Central Nervous System Stimulants Limit Caffeine Transport at the Blood–Cerebrospinal Fluid Barrier
por: Ikeda-Murakami, Kei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_obvgq43sjas1f8jmroq4ehg795